---
title: "Takeda Pharmaceutical Says NDA for Oveporexton Gets FDA Acceptance"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275444067.md"
description: "Takeda Pharmaceutical Says NDA for Oveporexton Gets FDA Acceptance"
datetime: "2026-02-10T10:57:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275444067.md)
  - [en](https://longbridge.com/en/news/275444067.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275444067.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275444067.md) | [繁體中文](https://longbridge.com/zh-HK/news/275444067.md)


# Takeda Pharmaceutical Says NDA for Oveporexton Gets FDA Acceptance



### Related Stocks

- [Takeda Pharmaceutical Company Limited (TAK.US)](https://longbridge.com/en/quote/TAK.US.md)
- [Takeda Pharmaceutical Co. Ltd. (4502.JP)](https://longbridge.com/en/quote/4502.JP.md)

## Related News & Research

- [Takeda Pharmaceutical to Cut 400 US Jobs, Invest in Blood Products](https://longbridge.com/en/news/277827484.md)
- [Takeda, Protagonist Say FDA Accepts New Drug Application for Potential Polycythemia Vera Treatment](https://longbridge.com/en/news/277429641.md)
- [FDA Accepts Takeda's Oveporexton Application for Priority Review in Narcolepsy Type 1](https://longbridge.com/en/news/275421654.md)
- [FDA nimmt Zulassungsantrag für Oveporexton von Takeda zur Prüfung an](https://longbridge.com/en/news/275421640.md)
- [Takeda, Kyoto University to End Decade-Long iPS Research Tie-Up](https://longbridge.com/en/news/274732289.md)